Universitair Medisch Centrum

Site:	Universitair Medisch Centrum	Go to their website
Address:	Heidelberglaan 100
City:	Utrecht
State:
Zip:	3584 CX
Country:	Netherlands

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075
1	Phase I, Combining Oral Topotecan With Oral Pazopanib	Ongoing, but not recruiting	Closed	Pazopanib (Votrient) + Topetecan (Hycamtin)	NCT00732420
1	Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients	Ongoing, but not recruiting	Closed	BKM120 + MEK162	NCT01363232